Company intelligence / Profile preview

WTI Clinical Trials

Hollywood, Florida, United States

Ownership: Private
Development stage: Other

Overview

WTI Clinical Trials is Teva’s internal South Florida clinical unit (Watson Therapeutics) operating since 1994 with a 204‑bed facility conducting over 60 early‑phase (primarily bioequivalence and PK) studies annually for both generic and innovative programs within Teva.[5]

Modalities: Small moleculeBiologicGeneric drugVaccine
Industry: Contract Research Organization

Partnerships

Internal clinical development collaborations with Teva generic and innovative R&D units

Beyond the preview

Go deeper on WTI Clinical Trials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WTI Clinical Trials.

Explore the full profile